North America Oxygen Concentrator Market Outlook, 2026

An oxygen concentrator is a device that concentrates the oxygen from a gas supply by selectively removing nitrogen to supply an oxygen-enriched product gas stream. The device can aid those whose oxygen saturation levels are between 88 and 92 by reducing the burden on the lungs. With the demand for medical oxygen continuing unabated and countries struggling to keep pace with demand, the oxygen concentrator has emerged as a sought-after device. The research report titled North America Medical Oxygen Concentrators Market Outlook, 2026 categorizes the market to forecast the revenues and analyze the trends in each of the following segments: based on product type (Portable, Stationary, & Oxygen Cylinders), based on technology (Continuous Flow & Pulse Flow), based on end users (Home Care & Non Home Care), based on North America countries & major companies.

Being the top market share contributor globally, North America’s market accounted for a value of USD 0.53 Billion historically in 2015. Apart from the already prevailing respiratory ailments, the COVID 19 pandemic had its part in the rapid increase in the demand for oxygen concentrators in the region. Invacare Corporations, which is one of the global leading companies, achieved a 72.2% increase in terms of sales in the last quarter of 2020, owing to the COVID outburst. COVID patients who do not require ventilator support can be treated with an oxygen concentrator. Moreover, patients can take oxygen therapy in the safety and comfort of their homes. The application of oxygen concentrators in the treatment of COVID-19 is a major reason for the sudden increase in demand in 2020. Through the forecasted period, the regional market is expected to show a growth of over 5.5%, retaining its market dominance with a decline in market share. Other major key players are Philips Health Care, AirSep Corporation, DeVilbiss Healthcare, Nidek Medical Products, Inc., Inogen, Inc., Inova Labs, Inc., O2 Concepts & others.

One of the biggest problems in the region is the growing geriatric population, which in turn has been a boost to the market growth. As per the United Nations Department of Economic and Social Affairs, the number of elderly people in Northern America is projected to grow by 41.0% by 2030. The frequency of increasing respiratory disorders among the aged population has allowed the oxygen cylinder segment to account for a value of USD 0.24 Billion in the year 2015. The increase in cases of respiratory disorders including asthma, COPD, fibrosis, and pulmonary hypertension among young adults is estimated as a driver for the portable oxygen cylinder segment in the region, which is to have an anticipated CAGR of 9%.

The easy availability in a large number, rapid technology development, and the growing prevalence of patients suffering from long-term respiratory disorders had allowed the continuous flow oxygen concentrators segment to account for a market share of over 85% in 2020. However, the pulse flow segment is expected to grow at a significant growth rate during the forecast period owing to its lightweight, high mobility, and suitability for patients having an active lifestyle. Being an ideal choice for the condition which requires low liters of O2 per minute, the pulse flow segment is looked forward to growing to a market value of USD 0.17 Billion by the end of the forecasted period.

In North America, the home care segment dominated the market as an end-user, holding more than half of the market share, and expected to show an incline in the market. It can be ascertained reason that the increase in home therapy for COPD is the root cause for this market dominance. Even though losing the market share, the nonhome care segment witnessed a lucrative market value of USD 0.29 Billion in 2020, due to the COVID outbreak. In terms of country, the USA holds a major market share, while all the rest countries could hardly manage a single-digit market share. There were more than 46 Million adults older than 65 years old in 2020 and is estimated to increase to 90 Million by 2050 in the USA. Along with this, a minimum of 16.4 Million people was suffering from COPD in 2018 in the country which in 2014 was at 14.9 Million. Such prevalence of respiratory disorders and the geriatric population is boosting the market potential in the country.

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For this study, the publisher has segmented the North America Medical Oxygen Concentrator Market report based on product, technology, end users, and countries:

CONSIDERED IN THE REPORT

• Geography: North America
• Base year: 2020
• Historical year: 2015
• Forecasted year: 2026

REGIONS COVERED:

• North America
• USA
• Canada
• Mexico

ASPECTS COVERED IN THE REPORT

• Market Size by Value for the period (2015-2026F)
• Market Share by Product (Portable Oxygen Concentrator, Stationary Oxygen Concentrator, & Oxygen Cylinders)
• Market Share by Technology (Continuous Flow & Pulse Flow)
• Market Share by End User (Home Care & Non Home Care)
• Market Share by Country
• Market Share by Company